Rocuronium Bromide Injection, Solution
Product Images NDC 0781-3220

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 0781-3220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rocuronium 01

Rocuronium 01
Chemical structure of Rocuronium Bromide showing its steroidal backbone with functional groups including a morpholine ring, hydroxyl group, acetate group, quaternary ammonium, and bromide ion.*
FDA Label Image

Rocuronium 02

Rocuronium 02
Boxplot chart showing distribution of a measured variable in minutes across different mg/kg doses of Rocuronium Bromide for three age groups: 18-64 years, 65 years and older, and 1-12 years. The vertical axis represents time in minutes, and the horizontal axis indicates dose levels in mg/kg.*
FDA Label Image

Rocuronium 03

Rocuronium 03
A box plot chart depicting data measured in minutes for different age groups (18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years) across various dosages (mg/kg). The vertical axis represents time in minutes, and the horizontal axis categorizes age groups with corresponding dosages shown below each group.*
FDA Label Image

Rocuronium 04

Rocuronium 04
A line graph showing time in minutes on the vertical axis and dose number on the horizontal axis for Rocuronium Bromide. It compares two dosage groups, 0.1 mg/kg and 0.15 mg/kg, with respective participant numbers of 29 and 13, illustrating changes over five dose administrations.*
FDA Label Image

Rocuronium 05

Rocuronium 05
Packaging label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) in multiple-dose vials. The label indicates it is for intravenous use only, with a warning that it is a paralyzing agent. The labeler is Sandoz Inc, a Novartis division. The package contains 10 vials, each 5 mL.*
FDA Label Image

Rocuronium 06

Rocuronium 06
Packaging label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) solution for intravenous use. The label indicates it is a prescription drug, a paralyzing agent, and is supplied by Sandoz Inc. The package contains 10 multiple-dose vials. The NDC number 0781-3220 is shown on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.